A fast cardiac gamma camera with dynamic SPECT capabilities: design, system validation and future potential by Bocher, Moshe et al.
ORIGINAL ARTICLE
A fast cardiac gamma camera with dynamic SPECT
capabilities: design, system validation and future potential
Moshe Bocher & Ira M. Blevis & Leonid Tsukerman &
Yigal Shrem & Gil Kovalski & Lana Volokh
Received: 31 October 2009 /Accepted: 27 April 2010 /Published online: 29 June 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract
Purpose The goal of this study is to present the Discovery
NM 530c (DNM), a cardiac SPECT camera, interfacing
multi-pinhole collimators with solid-state modules, aiming
at slashing acquisition time without jeopardizing quality.
DNM resembles PET since it enables 3-D SPECT without
detector motion. We further envision how these novel
capabilities may help with current and future challenges of
cardiac imaging.
Methods DNM sensitivity, spatial resolution (SR) and
energy resolution (ER), count rate response, cardiac
uniformity and cardiac defect contrast were measured and
compared to a dedicated cardiac, dual-head standard
SPECT (S-SPECT) camera.
Results DNM sensitivity was more than threefold higher
while SR was notably better. Significantly, SR was the
same for
99mTc and
201Tl. ER was improved on DNM and
allowed good separation of
99mTc and
123I spectral peaks.
Count rate remained linear on DNM up to 612 kcps, while
S-SPECT showed severe dead time limitations. Phantom
studies revealed comparable uniformity and defect contrast,
notwithstanding significantly shorter acquisition time for
the DNM. First patient images, including dynamic SPECT,
are also presented.
Conclusion DNM is raising the bar for expedition and
upgrade of practice. It features high sensitivity as well as
improved SR, temporal resolution and ER. It enables
reduction of acquisition time and fast protocols. Importantly,
it is potentially capable of dynamic 3-D acquisition. The new
technology is potentially upgradeable and may become a
milestone in the evolution of nuclear cardiology as it assumes
its key role in molecular imaging of the heart.
Keywords Cardiac gamma camera.Single photon
emission computed tomography.Myocardial perfusion
scintigraphy.Discovery NM 530c
Introduction
The technique of SPECT for myocardial perfusion scintig-
raphy (MPS) is the most common, non-invasive imaging
tool for risk stratification of patients with coronary artery
disease (CAD) [1–5]. Millions of studies are performed
each year, greatly exceeding other competing modalities
[6], such as PET or MRI, in spite of some advantages
offered by them. The growth of SPECT results from the
vast extent of CAD worldwide and its associated morbidity
and mortality, and enormous social and economic burden.
This situation has created an urgent need for an efficient,
non-invasive tool to risk-stratify patients and thus to direct
and monitor therapy. The need has perpetuated a continuous
effort to upgrade SPECT MPS [7–10].
Notwithstanding the growth and value of current
standard SPECT (S-SPECT) practice, it is limited and
needs to be transformed in order to remain a truly effective
tool. Of foremost concern are the costs of the technique.
Expenditures for health care in the USA have doubled over
the last 10 years [11, 12] and cardiovascular disease
accounts for 20% of these total costs. The growth rates of
imaging costs continue to outpace other medical services
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DOI 10.1007/s00259-010-1488-z[13] and stress imaging has grown 6% per year from 1993
to 2001 [14]. While, in theory, cutting procedure time could
have reduced costs, attempts to slash acquisition time are
limited with current SPECT technology. This is due mainly
to the low efficiency of the classic Anger gamma camera
and its parallel-hole collimation, and additionally to the
limited spatial resolution (SR) and energy resolution (ER)
of the sodium iodide crystal and the process of light
scintillation. Measurements of gamma photon position and
energy are derived from the many signals produced by a
large array of photomultiplier tubes. The individual signals
are statistically poor, and this limits both the SR and ER.
Limited ER leads to contamination of the image by
scattered gamma photons, leading to further deterioration
of SR and target to non-target contrast ratios. Marginal ER
often leads to instability of uniformity corrections and
degradation of the detector’s uniformity of response. The
collection of resulting errors may be propagated during
attenuation-corrected SPECT reconstruction [15].
A more fundamental limitation of conventional MPS is
the relative nature of its normalized output images. This
occurs because the interpretation model relies, sometimes
erroneously, on having at least one myocardial region with
normal perfusion. In CAD that involves all three major
arteries; the extent and severity of ischaemia will be
reduced because of the image normalization, and often
only the most severely underperfused areas will be detected
[16–19]. Sometimes, in “balanced ischaemia” and in left
main coronary stenosis, MPS may totally miss patients who
have a very high-risk coronary disease. Since the extent of
perfusion abnormality is critical in deciding which patients
would benefit from coronary revascularization, such under-
estimation of the extent of disease is a major limitation of
S-SPECT that needs to be overcome [20–22]. Several
innovative attempts to measure myocardial blood flow
(MBF) and coronary flow reserve (CFR) with S-SPECT
technology have been carried out, but have not gained wide
clinical acceptance [23–27]. This situation reflects both the
recognition of the need for such measurements as well as
the technical difficulties and limitations involved. Since
MBF and CFR can be measured by PET [28, 29], a large
body of respected researchers has been predicting the
emergence of PET as the primary MPS tool for a
considerable time [30–34]. Interestingly, such adoption of
PET for MPS has not yet occurred despite the abundance of
PET/CT scanners in recent years. The expressed customer
preference may be related to the ease of use and availability
of both SPECT radiopharmaceuticals and equipment.
Awareness of the above-mentioned limitations of S-
SPECT motivated our team to design and create a new
ultra-fast cardiac SPECT camera, denoted the Discovery
NM 530c (DNM) (Fig. 1), in order to provide the medical
community with the simultaneous benefits of both conve-
nient and cost-effective logistics and improved image
quality. The DNM technology combines a multi-pinhole
collimator block interfaced with a multidetector array of
pixelated cadmium zinc telluride (CZT) modules (Fig. 2).
Its design is inspired by multi-pinhole collimation SPECT
technology, introduced years ago [35], and by its recent
adaptation for pre-clinical microSPECT as well as clinical
SPECT [36–41].
In DNM, the detectors and pinholes are all focused on
the heart organ in order to maximize the imaging sensitivity
there. The miniature pixels and miniature size of the CZT
modules allows the packing and arrangement of multiple
detectors in DNM with sufficient proximity and coverage to
ensure that 3-D sampling of the heart provided by
stationary acquisition is sufficient for tomographic recon-
struction. Unlike traditional pinhole collimation that uses
magnification, in DNM imaging, minification is used
(Fig. 2b). In this case system resolution is preserved
because of the small pixels and high intrinsic resolution
the CZT technology [40, 41]. This matching allows a
reduction in detector size without loss of resolution. The
savings in detector area allows the economical construction
of multiple detectors, each with a full view of the heart.
Since each detector is stationary, it has the full acquisition
time to acquire the image. Even a few minutes of
acquisition time is more than enough to outperform the
sensitivity of a rotating S-SPECT camera, where typically
Fig. 1 Left: the Discovery NM
530c (DNM) featuring a gantry
that is similar to a conventional
cardiac SPECT camera, with a
different detector assembly that
is completely stationary during
acquisition. Right: hybridization
of the DNM camera with a
multidetector CT camera
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DNM is an inherently tomographic technology, which
similar to PET is potentially capable of truly dynamic
tomographic study that is required for quantitative MPS.
The aim of this manuscript is to describe the technolog-
ical concepts underlying the DNM design, to measure and
compare DNM features to state-of-the-art S-SPECT tech-
nology, and to forecast how those improved capabilities
will promote new significant changes in clinical practice
and may influence the evolution of nuclear cardiology.
Materials and methods
System description
The DNM gantry is similar to that of an S-SPECT gamma
camera, yet its detector assembly is radically new. The
detector assembly comprises a multi-pinhole collimator
block, where each pinhole illuminates a solid-state pixe-
lated, gamma ray detector made of CZT (Fig. 2). Thus,
each pinhole and detector constitutes a complete miniature
gamma camera.
In CZT, an absorbed gamma ray is converted directly to
an electric charge. In S-SPECT with scintillation crystals,
an absorbed gamma ray is first converted to ultraviolet light
and only then to an electric charge in an “indirect” process.
The indirect process is inefficient and is then followed by a
high amplification step in the photomultiplier tube, result-
ing in limitation to the overall accuracy of the measured
energy and position of the incident gamma rays. In CZT
these limits are overcome by a “direct” signal of electron
hole pairs that is ∼50 times bigger than the signal being
amplified in the S-SPECT system. Thus, the ER is
dramatically improved by the statistics of the collected
signal. A known limitation of the ER in CZT results from
depth of interaction effects in the detector material;
however, this effect is measurably reduced in pinhole
collimation geometry because of the oblique angles of
incidence which reduce both the mean depth of interaction
and the variability of these depths [41].
The intrinsic SR of the CZT technology is determined by
the combination of the pixel size where the gamma photons
are absorbed and the system geometry. The CZT pixels are
physically 2.46×2.46 mm in size and have negligible
crosstalk due to the direct conversion to an electric charge.
In contrast conventional S-SPECT pixels do share signals
because of the spreading of light between them and this
crosstalk degrades their effective pixel size. The optimized
small pixel size of DNM allows a significant minification
without loss of resolution compared to conventional
systems. Overall, the DNM system detector contains 19
detector heads of 8×8 cm. The detector heads are directed
towards the heart so as to sample signals from the heart and
the region around it. The target volume for high quality
imaging in which the patient heart is positioned is
approximately a sphere of 19 cm diameter. Once the patient
is positioned on the imaging table, the position of the
gantry is adjusted so that the heart is close to the centre of
the field of view (FOV). An automatic algorithm can guide
the operator to the best positioning.
Importantly, the intrinsic SR is independent of photon
energy. In particular, for isotopes with low energy photons
like
201Tl where intrinsic SR is a limiting factor for S-
SPECT, the SR may be greatly improved and become
similar to
99mTc. Another source for SR degradation in S-
SPECT is septal penetration and scatter in the parallel-hole
collimator by high energy photons emitted by
123I and
201Tl
radiopharmaceuticals or from isotopic impurities. The well-
shielded pinhole collimator may be free of these processes
Fig. 2 Components of the detector assembly. a Multi-pinhole
collimator covering the heart volume. b Pinhole collimation and
miniaturization of the detector enable proximity to the heart with
minification of the heart image, utilizing most of the detector surface
to cover the heart projection. c A 4×4 cm CZT detector size as
compared to a classic photomultiplier tube of a conventional SPECT
camera. d The detector box with its rear electronic connections. e The
CZT is pixelated featuring intrinsic resolution of about 2.5 mm
irrespective of photon energy
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99mTc. Each CZT pixel is an independent detector provided
with its own electronic processing unit using miniaturized
attached electronics (Fig. 2d). Therefore the DNM may be
capable of linear detection response even at very high count
rates. This is not possible with S-SPECT where only two
independent detector electronic chains exist, one for each
head of the camera, and therefore detector processing dead
time results in significant event losses and pile-ups, at high
count rates. Since the DNM gantry does not move during
acquisition and since all detectors are acquiring data from
the same source simultaneously, the measured projections
are temporally consistent and the reconstructed data may be
termed “inherent and instantaneously tomographic”. In this
respect DNM imaging resembles PET imaging that features
temporal consistency of data acquired into projection views
that may be beneficial for applications requiring dynamic
information. The DNM is thus designed to acquire all types
of cardiac SPECT procedures including multigated tomog-
raphy and dynamic images. In addition to “on-the-fly”
reconstruction the DNM saves each event of the acquired
data in a list-mode format including its energy, spatial
information, time of occurrence and gated ECG trigger, for
later specialized analysis.
Reconstruction algorithm For DNM,dedicated image recon-
structionwasdeveloped.SPECTreconstructionisbasedonan
implementation of a 3-D iterative Bayesian reconstruction
algorithm [42] combining accurate modelling of DNM
geometrical and physical characteristics with optimized
statistical techniques. An adaptation of one-step-late Green’s
prior [43] was used to control smoothness of the reconstruc-
tion; 30–50 iterations of the algorithm were used for
reconstruction of phantom and clinical data. Post-
reconstruction, a Butterworth filter with a cut-off frequency
of 0.37 cycles/cm and power of 7 was applied. Fine-tuning
of the reconstruction algorithm parameters, optimized sepa-
rately per type of acquisition (e.g. low-dose, high-dose), was
based on the optimal trade-off between reconstructed
uniformity of healthy myocardium and contrast of perfusion
defects, using extensive phantom studies [44].
In the following experiments, whenever it was relevant,
we have compared imaging capabilities of the DNM system
to a state-of-the-art, cardiac-dedicated, dual-head S-SPECT
camera (Ventri, GE Healthcare).
SPECT sensitivity
The count sensitivity of the two cameras (DNM and S-
SPECT) for
99mTc with energy window set at 140.5 keV ±
10% was compared using the cardiac insert of an
anthropomorphic torso phantom (Data Spectrum), in air
without any scatter material. The patient volume that is
fully seen by all detectors is denoted the quality FOV
(QFOV) For the DNM two different phantom locations
were tested: (1) at the centre of the QFOVand (2) the point
closest to the camera body within the QFOV. The same
phantom was used for sequential sensitivity measurements
on both DNM and S-SPECT systems. The measurements
were corrected for decay. Sensitivity was calculated as
counts/s per MBq.
Energy resolution
Spectra of
99mTc,
201Tl and
123Iw e r em e a s u r e du s i n ga
method similar to the “intrinsic ER” test defined in NEMA
NU-1 2001 standard section 2.2, on both DNM and S-
SPECT detectors without collimation, using a point source.
ER was calculated by measuring full-width at half-maximum
(FWHM) as percentage of peak position. ER is important for
scatter rejection from image data as well as intrinsic
uniformity and calibration stability. In addition, energy
spectra of combined
99mTc and
123Iw e r em e a s u r e dt o
evaluate simultaneous
99mTc/
123I dual isotope acquisition
capabilities of both systems.
Collimator penetration in
123I imaging
A
123I point source of 88.8 MBq activity located at a distance
of 15 cm from the collimator was imaged in planar mode on
an S-SPECT system and in one of the DNM collimated
detectors to visualize respective collimator penetration.
SPECT resolution (with scatter)
SPECT resolution with scatter was measured using three
99mTc point sources (1.5×1.5×1.5 mm) placed according to
NEMA in a cylindrical phantom filled with water. The
phantom centre was placed 15 cm away from the external
surface of the collimator. The two-dimensional (X and Y)
activity profiles were plotted and FWHM calculated for
each of the three point sources; the results of the central,
radial and tangential resolutions as defined by NEMA
protocol are reported. The following reconstruction param-
eters were used for DNM: reconstruction type: maximum
likelihood expectation maximization (MLEM), number of
iterations: 250, reconstruction voxel size: 2×2×2 mm, and
for S-SPECT: reconstruction type: filtered backprojection
(FBP), reconstruction voxel size: 1.6×1.6×1.6 mm. No
filters were used for both modalities. Additional similar
measurements were performed for
201Tl point sources. Note
that while the S-SPECT result is fully compliant with
NEMA protocols, FBP is not possible with the DNM and
therefore the result is not compliant with the NEMA
protocol.
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The count rate performances of the DNM and of the S-
SPECT were measured to assess the count rate linearity,
especially at high rates. Good count rate performance is
crucial for quantitative dynamic SPECT applications, such
as CFR measurements performed on data acquired during
the passage of an injected bolus through the heart
chambers. Since CFR and left ventricular ejection fraction
(LVEF) measurements both require very high temporal
resolution, of the order of 1 s or even faster, very high
count rates are mandatory for a good image. However, high
count rates often cause a non-linear camera response that
significantly reduces accuracy. Therefore both high camera
sensitivity and count rate linearity are required.
For S-SPECT, measurements were based on NEMA NU-
1 guidelines and were performed accordingly: without
collimation and using a decaying
99mTc source. Since
multi-pinhole collimation is an integral part of the DNM
system, the measurements were performed with collima-
tion. The DNM measurements were performed using the
multiple calibrated source method: 12 syringes with
increasing activity from 199.8 to 1,994.3 MBq (53.9 mCi)
of
99mTc were sequentially placed at the centre of the
QFOV. The counts measurement was performed on S-
SPECT using an acquisition mode that was dedicated for
high count rates. The DNM has only one standard
acquisition mode for all count rates. The energy window
was the same for both systems, i.e. 140.5 keV ± 10%. The
DNM was configured to stop the acquisition when the
count rate exceeds a predetermined electronic throughput
computer limit.
Phantom studies of
99mTc myocardial perfusion SPECT
Series of anthropomorphic torso phantom (Data Spectrum)
acquisitions were performed in order to evaluate image
quality in multiple imaging scenarios relevant to clinical
practice. The main clinical task for MPS is detection and
characterization of perfusion defects; thus useful images
should achieve uniform uptake within normally perfused
myocardium and delineate myocardial perfusion defects in
pathological situations. To capture this, we have compared
S-SPECT and DNM performance by measuring the trade-
off between uniformity of normal myocardium and contrast
of perfusion defects for manufacturer-recommended acqui-
sition parameters with a standard camera and short
acquisition times intended for clinical use of DNM.
Phantom preparation and acquisition
Image data were acquired using a Data Spectrum anthro-
pomorphic torso phantom with heart, lungs and liver
inserts, and with inserts simulating myocardial perfusion
defects (Fig. 3). The phantom was prepared to simulate
realistic
99mTc activities encountered during the low-dose
rest and high-dose stress parts of the standard 1-day
myocardial perfusion protocol. In addition, breast inserts
were used to simulate variations of female anatomy and the
liver inserts were loaded with normal and high activities.
Perfusion defect inserts were placed in two different
locations within the myocardial wall. Manufacturer-
recommended parameters, including acquisition times, were
used for the standard SPECT camera—12.5 min and 10 for
low- (rest) and high-dose (stress) conditions, respectively.
The standard acquisition protocol for the S-SPECT camera
resulted in acquisition of 60 projections, evenly spaced over
a 180° arc, from right anterior oblique to left posterior
lateral view. DNM acquisition times were determined based
on prior phantom experiments measuring ratios of volu-
metric sensitivity within the heart region, compared to S-
SPECT, and were 5 and 3 min, respectively. Reconstruction
parameters optimization for DNM was based on extensive
prior phantom experimentation, aiming at optimal trade-
offs between uniformity of healthy myocardium and
reconstructed contrast of perfusion defect, which would be
similar to those acceptable for traditional SPECT devices;
50 iterations of penalized maximum likelihood reconstruc-
Fig. 3 Imaging of anthropomorphic torso phantom by the DNM
camera with male (upper right) and female (upper left) configurations.
Bottom: transaxial CT slice of the phantom with middle-sized breast
extensions and defect inserts in septal and lateral walls
Eur J Nucl Med Mol Imaging (2010) 37:1887–1902 1891tion were used for high-dose acquisitions and 40 iterations
for low-dose acquisitions. Post-reconstruction, a 3-D
Butterworth filter was applied with the following parame-
ters: cut-off frequency of 0.37 cycles/cm and power of 7.
Uniformity-contrast analysis
For the purpose of uniformity-contrast analysis, registered
phantoms of uniform activity and those containing defect
pairs were acquired in series containing five to ten
repetitions for each condition. Reconstructed transaxial
slices were re-oriented into standard cardiac oblique
images. Stacks of short-axes slices were used for myocar-
dial wall segmentation and measurement of reconstructed
activity at the left ventricular wall surface using standard
myocardial perfusion segmentation software (LVSD, GE
Healthcare). These values were used for calculation of
uniformity and contrast metrics. Normalized standard
deviation (NSD) was used to characterize uniformity for
healthy heart with uniform activity and effective contrast
(EC) to characterize reconstructed contrast for known
defect locations and volumes. The metrics were calculated
as follows:
NSD ¼
SDðcÞ
c
  100%
EC ¼
c
  ðÞ
i2D   c
þ ðÞ
i2D
c
ð Þ
i2D
  100%
where c
þ ðÞ
i2D is the mean estimated count on mid-myocardial
surface in the known volume of defect insert in defect-present
(+) phantom, while (-) denotes an area without a defect. NSD/
EC plots were generated for matching sets of DNM and S-
SPECT data. We further compared DNM reconstructed
perfusion distribution with S-SPECT for a series of uniform
phantoms. Data consistency was analysed using normalized
activity scores in myocardial segments conforming to a 17-
segment heart model [45]. A segmental score S was defined
as the ratio of mean value on the mid-myocardial surface
within the segment to maximum value on the mid-myocardial
surface across the entire myocardium. Correlation for
segmental scores between DNM and S-SPECT over a
number of phantom measurements was performed.
Dynamic SPECT
A total of 370 MBq of
99mTc-MIBI was injected in a resting
patient’s left arm while lying on the camera table. A list-
mode dynamic acquisition was started simultaneously with
the injection and continued for 5 min, allowing offline
division of the data into various time intervals. The first
90 s were segmented to intervals of 3 s per step.
Attenuation correction was performed using a map obtained
from a dedicated CT imaging device. The data of each time
interval were reconstructed separately resulting in 30
attenuation-corrected volumes each consisting of a set of
transaxial slices. In addition, a volume containing data from
the entire 5-min acquisition was generated and a region of
interest (ROI) was drawn inside the left ventricular cavity.
This ROI was copied to the other 30 volumes and the
counts within it were measured and a left ventricular cavity
time-activity curve was generated.
Results
SPECT sensitivity
Sensitivity results (Table 1) show three- to fourfold higher
sensitivity of the DNM compared to S-SPECT for the
cardiac phantom in air.
Energy resolution
Table 2 demonstrates an almost twofold increase in ER as
measured on DNM for both
99mTc and
123I isotopes and a
slight increase in DNM ER for
201Tl as well. Figure 4
shows the energy spectra of
99mTc for DNM and S-SPECT.
Simultaneous dual isotope
99mTc/
123I energy spectrum
Figure 5 shows significantly increased separation of
99mTc
and
123I energy peaks on DNM as contrasted with S-
SPECT. In addition, the S-SPECT spectra show two
fluorescence peaks for Pb at 75 and 85 keV originating at
the parallel-hole collimator. Septal penetration and scatter
of higher energies of
123I radiopharmaceuticals and also
impurities (
124I) contaminating the
123I are also noted on
S-SPECT alone and imaged as a star artefact on Fig. 6.
Scan phantom position Sensitivity (counts/s per MBq) Sensitivity (DNM)/sensitivity
(S-SPECT)
DNM QFOV centre 656.8 3.19
DNM max. rate in QFOV 848.4 4.13
S-SPECT 205.7
Table 1 Comparison of DNM
and S-SPECT sensitivity.
S-SPECT sensitivity, being
independent of location, is
measured only once
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The central, radial and tangential resolution (Table 3) are
calculated according to NEMA NU-1 for both DNM and
S-SPECT. The measurements demonstrate higher resolution
for DNM compared to S-SPECT in each direction.
Importantly, DNM SR for
201Tl is similar to that of
99mTc.
The image of the
201Tl point sources (Fig. 7) clearly shows
the better resolution of DNM achieved by the combined
effect of higher intrinsic detector resolution, better statistics
and no collimator penetration by high energy photons.
Count rate performance
Figure 8 shows linear count rate response of the DNM
system up to the system limit. Maximal count rate
measured was 612.2 kc/s with activity of 1,957.3 MBq
(52.8 mCi) with no significant dead time losses up to the
point where the computational system limit was reached
with 1,994.3 MBq (53.9 mCi) dose at an actual count rate
of 624.6 kc/s. In addition, the S-SPECT camera showed
non-linear response with saturation and even paralysis at
high count rates with a maximum of 320 kc/s, while NEMA
criterion for 20% loss was reached at 210 kc/s.
Phantom studies of
99mTc myocardial perfusion SPECT
Table 4 shows uniformity and contrast measurements of
phantom experiments simulating low-dose rest MPS
acquisitions. Overall, notwithstanding the significantly
shorter acquisition time of DNM, uniformity and defect
contrast trade-off is comparable or sometimes even better
then S-SPECT. For yet unexplained reasons, DNM advan-
tage was consistently more prominent for the septal defect
compared to the lateral defect. A sample of reconstructed
images of the anthropomorphic torso phantom is shown in
Fig. 9. “Per-segment” analysis (Fig. 10) shows good
correspondence in values of segmental scores between
DNM and S-SPECT, with a correlation coefficient of 0.92.
Dynamic SPECT
The dynamic time-activity curve of the bolus passage
through the left ventricle is shown in Fig. 11.
Discussion
Improved image characteristics
Our data show that DNM has superior sensitivity, SR
and ER (Tables 1, 2 and 3) and therefore it may sustain a
significant expedition and upgrade of clinical practice.
The increased sensitivity is of immediate practical value
since it may lead to a large reduction in acquisition time
without jeopardizing image quality. Indeed, the trade-off
between homogeneity of the normal segments and the
defect contrast was shown in our phantom experiments to
usually be comparable to DNM in spite of its shorter
acquisition time (Figs. 9 and 10,T a b l e4). Our measure-
ments on phantoms have now been augmented by patient
data from a recent multi-centre trial [46]. Using a 1-day
99mTc-tetrofosmin rest/stress protocol in 165 patients, the
authors have found that DNM provides diagnostic perfor-
mance comparable to S-SPECT, on both per-patient and
per-vessel analyses, while DNM acquisition time was 6-
and 3.5-fold shorter than S-SPECT on rest and stress
images, respectively. In addition, superior image quality
was scored on DNM images. Figure 12 presents the
images of one of the patients.
The enhanced ER demonstrated in DNM improves
scatter rejection and thus contributes to image contrast. It
can also facilitate the separate imaging of simultaneously
acquired multiple different isotopes. In particular, the
improved separation between the energy peaks of
99mTc
and
123I and the lack of
123I septal penetration for the
pinhole collimators (Figs. 5 and 6) are expected to lead to a
variety of novel
99mTc/
123I dual isotope protocols. Another
Table 2 ER calculated on the energy spectra curve as percentage of
FWHM from peak position energy and its corresponding keV value.
ER is better on DNM for all three isotopes
Isotope ER DNM, % (keV) ER S-SPECT, % (keV)
99mTc 5.4 (7.6) 9.4 (13.2)
123I 5.8 (9.2) 9.0 (14.3)
201Tl 11.7 (8.2) 13.4 (9.4)
Tc99m Spectrum
0 25 50 75 100 125 150 175
Energy (KeV)
DNM S-SPECT
Fig. 4 Tc-99m energy spectra of DNM (blue)a n dS - S P E C T( pink).
Better energy resolution is demonstrated for the DNM (5.4%) as
compared to S-SPECT (9.4%)
Eur J Nucl Med Mol Imaging (2010) 37:1887–1902 1893important feature of pixelated CZT imaging, which is
advantageous for dual isotope protocols, is the common
SR for all energies and isotopes. Thus, the SR for
201Tl is
the same as
99mTc (Table 3 and Fig. 7). Lower
201Tl
resolution in S-SPECT has been a source of decreased
contrast on
201Tl images and also a source of mismatch in
the comparison of stress/rest left ventricular sizes in current
99mTc/
201Tl dual isotope protocols.
The DNM technology has other practical advantages;
since each detector pixel has independent electronic signal
readout and processing, it is therefore capable of accurate
count measurements even at very high count rates, where
S-SPECT cameras with their single large detector crystals
fail (Fig. 8). We denoted this as “high rate count linearity”.
Critically, since the gantry of DNM does not move during
acquisition and since all detectors are therefore acquiring
the data from the source simultaneously, the projection
images recorded are therefore all consistent in the time
domain. That is, patient motions and isotope distributions
are the same for each and every projection image submitted
to the reconstruction module. This aspect of the data
resembles PET imaging and its advantages; we denote it
as “inherently tomographic imaging”. Importantly, data
acquired in a short time interval is also reconstructable,
allowing even further reduction of the acquisition time
when necessary, e.g. in emergency scenarios. Since images
can be reconstructed on the fly, acquisition can be
terminated at a preset count density or when the data
becomes sufficient for diagnosis. Because of its inherent
tomographic features, the DNM is capable of dynamic
tomographic sampling with high temporal resolution of the
left ventricular cavity and the myocardium during the initial
passage of an injected bolus through the heart chambers
(Fig. 11). These data are the classic input for compartmental
modelling aimed at absolute CFR measurements.
Besides reducing acquisition time, the increased sensitivity
of the DNM may alternatively enable a cost-saving reduction
in radiopharmaceutical dosage and a corresponding reduction
in patient radiation exposure, all options that contribute to
flexibility and cost-effectiveness in the nuclear cardiology
clinic. In addition, faster patient procedures allow more
economicalusage ofthe totaldosethatispreparedinadvance,
especially in the setup of a 1-day rest/stress protocol using
99mTc-based MPS tracers. This logistic advantage is very
relevant today, due to the shortage of
99mTc generators in
northern America [47]. The short acquisition times and the
small footprint may enable use near the coronary care unit
itself, employing long-standing protocols [48, 49] for MPS
in scenarios of acute coronary syndrome. Alternatively,
scientists and clinicians concerned with the best image
quality may utilize the DNM sensitivity to acquire higher
statistics still in a relatively short time. For example, more
precise gated acquisition with more and hence shorter gate
intervals may allow the algorithmic creation of de-blurred
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Fig. 5 Clear separation of
99mTc and
123I energy peaks
on DNM as contrasted with
S-SPECT. In addition, the
S-SPECT spectra show two
fluorescence peaks for Pb at 75
and 85 keV originating at the
parallel-hole collimator. Septal
penetration and scatter of higher
energy photons associated with
the
123I dose are also noted on
S-SPECT alone
Fig. 6
123I images. Left: planar
image from S-SPECT system
demonstrates a “star effect” due
to parallel-hole collimator septal
penetration and scatter of higher
energy photons associated with
the
123I. Right: “planar” image
on a single collimator-detector
module of DNM system has no
“star effect”
1894 Eur J Nucl Med Mol Imaging (2010) 37:1887–1902perfusion images free of both respiratory motion and cardiac
motion artefacts [50, 51]. Such de-blurring is an essential
preliminary step before any hardware improvement of SR
can become effective. In addition, an increased number of
gates may be used for new applications that are related to
myocardial electrical conduction and contractility that are
currently being developed [52]. Patient motion itself and its
consequential artefacts may be reduced because of increased
patient comfort and cooperation during the short acquisitions.
Furthermore the inherent tomographic imaging may poten-
tially enable 3-D patient motion correction including rotation,
while S-SPECTmethods canusuallydirectlyaccount onlyfor
translations. In addition, S-SPECT artefacts resulting from
temporal inconsistency, such as the “upward creep” artefact,
whichiscreatedwhentheheartgraduallymovesupduringthe
S-SPECTcamera rotation [53, 54], may be less of a problem
with the temporally consistent DNM projections.
The DNM higher sensitivity and its improved SR and
ER for
201Tl (Tables 2 and 3 and Fig. 7) are expected to
significantly improve imaging with this isotope. This
perfusion tracer has known physiological advantages [55],
but yields poorer statistics, because of its longer half-life
and lower energy. Even though useful gated
201Tl images
have been obtained with modern S-SPECT cameras [56,
57], usage had been limited by image quality. Since
201Tl
acquisition commences almost immediately after stress,
improved gating with
201Tl, using DNM, is expected to
result in increased detection of myocardial stunning, which
is indicative of severe CAD. Similarly, improved image
quality is expected to support improved characterization of
myocardial viability when using 24- or even 48-h delayed
images, the latter being impractical with S-SPECT. Inter-
estingly, improving the quality of
201Tl images has recently
become more pertinent due to the shortage of
99mTc
generators in northern America [47, 58]. Figure 13 shows
images of a patient study using a
201Tl protocol demon-
strating comparable images of DNM and S-SPECT in spite
of much shorter acquisition time on DNM.
Table 3 Central, tangential and radial resolution calculated according
to NEMA NU-1 for both DNM and S-SPECT for point sources filled
with
99mTc or
201Tl
DNM
201Tl
99mTc
5.8 6.1 Central (mm)
2.9 3.1 Tangential (mm)
4.0 4.3 Radial (mm)
S-SPECT
201Tl
99mTc
13.7 10.9 Central (mm)
11.7 7.5 Tangential (mm)
15.4 10.9 Radial (mm)
Tl-201 PSF DNM
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Fig. 7
201Tl point sources as
imaged on a dedicated conven-
tional cardiac SPECT camera (a)
and DNM (b), clearly demon-
strating the higher resolution of
the DNM. In addition
corresponding line profiles
reveal the degrading effect of
septal penetration of the parallel
hole collimator on S-SPECT
resolution (c), while no septal
penetration is evident on
DNM (d)
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considered; a major theoretical concern is incomplete
sampling of data. This may occur since the DNM
collimation is concentrated on the heart vicinity and may
unevenly sample extracardiac activity. Our phantom studies
that included various degrees of liver activity, as well as a
recent multi-centre clinical trial, did not reveal explicit
problems, so far. However, this potential theoretical
limitation should be addressed by special studies designed
to evaluate the actual effect, and especially for optimizing
the accuracy of quantitative dynamic measurements. An-
other limitation of our study relates to the difficulty in
comparing such radically different technologies, especially
when standardized quality control procedures, like NEMA,
do not exist for DNM. In particular, the SR measurements
(Table 3) had to be done using different reconstruction
algorithms, FBP for S-SPECT and MLEM for DNM. Since
measurements were performed on point sources, they may
not ideally reflect the actual resolution that would be
achieved in real-world clinical scenarios.
Expedited new protocols
In addition to shorter acquisition times, the DNM may
allow fast MPS protocols with back-to-back stress/rest
gated SPECT acquisitions, significantly shorter than 1 h,
while occupying the camera for no more than 15 min total.
There are at least three different ways. The first possibility
is using stress/rest subtraction protocols. Such protocols
shall begin with a stress acquisition. If stress data are
abnormal, another dose is injected while the patient is
resting within the camera, followed by another acquisition
3 min later and then image subtraction. Better subtraction is
expectedwithDNMshortacquisitionbecauseofthereduction
in patient motion and myocardial shift. The 3-min wait for the
second acquisition is similar to the time needed for patient
positioning for a second separate acquisition in S-SPECT.
Moreover, this time may be used for dynamic gated
acquisition of the injected bolus.
A second fast protocol that may be facilitated by DNM
is simultaneous dual isotope imaging, for example
99mTc
and
201Tl following stress and rest injection, respectively.
Such protocols have been evolving for S-SPECT [59–61]
and may now reach maturity, because of the available DNM
detector performance.
A third fast MPS protocol is the reconsideration of
tracers that are rapidly washed from the myocardium
because of the high sensitivity and simultaneous views
data. A very interesting tracer is
99mTc-boronic acid
teboroxime (BATO), an FDA-approved tracer that is close
to Saperstein’s[ 62] definition of an ideal myocardial
perfusion tracer. BATO’s extraction fraction is higher than
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Fig. 8 Count rate performance with both systems operating at optimal
mode for high count rate using
99mTc sources. According to NEMA
guidelines the incident rate is determined by assuming that it is equal
to the rate observed on the camera at low doses, while higher doses
are normalized accordingly. The curves demonstrate linear count rate
response of the DNM system (blue line) up to the system computer
limit and non-linear response with saturation and even paralysis of
S-SPECT (pink line). The maximal rate achieved with DNM is almost
twice of what can be achieved with S-SPECT. No count loss is noted
with DNM, while NEMA criterion for 20% loss was reached at
210 kc/s on S-SPECT
Table 4 Results of uniformity and contrast measurements for phantom experiments simulating low-dose rest part of MPS acquisition, including lateral
andseptalwalldefectinserts.EachmeasurementrepresentsaseriesoftenphantomacquisitionsperformedsequentiallyonDNMandS-SPECT(Ventri).
Overall, notwithstanding the significantly shorter acquisition time of DNM, uniformity and defect contrast trade-off are comparable to S-SPECT
Male phantom configuration mean (SD) Female phantom configuration mean (SD)
DNM S-SPECT DNM S-SPECT
NSD, % 12.5 (1.0) 13.6 (1.35) 14.9 (0.98) 17.5 (2.55)
Lat EC, % 38.5 (4.75) 30.5 (8.5) 37.5 (6.35) 42.3 (6.05)
Sep EC, % 28.5 (4.1) 14.2 (5.55) 33.8 (5.8) 20.3 (10.55)
SD standard deviation, NSD normalized standard deviation, Lat lateral wall defect, EC effective contrast, Sep septal wall defect
Table 4 Results of uniformity and contrast measurements for phantom
experiments simulating low-dose rest part of MPS acquisition, including
lateral and septal wall defect inserts. Each measurement represents a series of
ten phantom acquisitions performed sequentially on DNM and S-SPECT
(Ventri). Overall, notwithstanding the significantly shorter acquisition time of
DNM, uniformity and defect contrast trade-off are comparable to S-SPECT
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201Tl or
99mTc tracers and its myocardial uptake
remains a near-linear function of flow even at high flow
rates [63, 64]. Its initial myocardial uptake as well as its
segmental washout rate correlate well with coronary blood
flow, providing two different targets for quantitative
measurements [23, 65]. Moreover, the high myocardial
extraction and rapid biological clearance allow for very
short stress/rest protocols [66]. The differential washout of
BATO may produce filling of stress perfusion defect within
a few minutes of early delayed images in a high percentage
of patients, potentially eliminating the need for a second
rest injection [67]. In spite of BATO’s unique qualities, it
never gained wide usage. Acquisition and tomographic
reconstruction of rapidly changing myocardial distribution
with rotating S-SPECT technology is prone to inconsisten-
cy errors. Another issue was high concentration in the liver
[68]. These barriers led to the disappearance of BATO from
mainstream nuclear cardiology practice [69]. A recent
simulation study [70] showed that a stationary SPECT
camera might suit dynamic BATO studies better than a
rotational S-SPECT camera. Indeed, with DNM, using
adenosine or regadenoson [71] stress, with BATO injected
when the patient is inside the camera, a high count rate
stress/redistribution study may be completed in less than
10 min. If both perfusion and function are normal or if
perfusion is abnormal but redistribution is noted in all
defects, a separate rest BATO injection may be omitted.
Otherwise, 15 min later and onward, a separate rest
injection followed by a 5-min acquisition may be per-
formed, completing a back-to-back stress/rest study in just
about 30 min and occupying the camera for about 15 min.
Hybrid non-invasive CAD diagnosis: “the best of both
worlds”
Currently, accurate structural imaging of CAD can be
obtained non-invasively with multidetector computed X-ray
tomography (MDCT) [72]. However, when the ability of
MDCT to detect ischaemia was tested against MPS, several
studies [31, 73, 74] have found that while MDCT is
consistently associated with outstanding negative predictive
values (usually >90%) it provides only mediocre positive
predictive values (29–44%). The ultimate value of a CAD
imaging modality does depend on its ability to optimally
assign the best treatment strategy to patients, especially
differentiating between medical therapy and invasive
revascularization [75]. The ability of MDCT to meet this
challenge is problematic, given that even invasive diagnostic
Fig. 10 Distribution of segmental scores for a series of ten uniform
phantoms acquired under conditions mimicking low-dose rest acqui-
sition. Blue: DNM short acquisition time. Orange: S-SPECT (Ventri)
with longer acquisition time. Error bars represent two standard
deviation values showing variability within corresponding series.
Most segments show comparable mean scores and the differences
between the scores of the two modalities are similar to their intrinsic
variability
Fig. 9 Samples of phantom comparisons: tomographic slices and
corresponding polar plots obtained using a low-dose rest acquisition.
Left panel: DNM (3-min acquisition). Right panel: S-SPECT (15-min
acquisition). Upper row: male configuration without a defect. Middle
row: female configuration with medium-sized breast inserts and with
perfusion defects in the septal and lateral walls. Lower row: male
configuration with hot liver and without a defect. Images are quite
comparable in spite of fivefold shorter acquisition time on the DNM
Eur J Nucl Med Mol Imaging (2010) 37:1887–1902 1897angiography, the gold standard of coronary anatomy, is
suboptimal for the task [76, 77]. Since DNM is also a small
footprint camera and its short acquisition time resonates well
with MDCT acquisition time, their optional usage in concert
may help to efficiently arrive at a comprehensive diagnosis.
This hybrid design concept (Fig. 1) is a continuation of “the
best of both worlds” idea that underlined the creation of the
Hawkeye—the archetypical, first clinical SPECT/PET/CT
[78]. In the context of CAD, such hybridization may evolve
into a new type of diagnostic cardiac lab, where the decision
to revascularize is made based on non-invasive procedures
that are physically, temporally and conceptually separated
from the invasive action.
Dynamic SPECT and the comeback of “first pass”
DNM high sensitivity combined with its dynamic SPECT
capabilities may cause renewed interest in radionuclide
angiocardiography, traditionally known as “first pass” (FP)
[79], however, in a new tomographic form. The use of FP,
one of the first breakthroughs in the history of nuclear
medicine, has almost vanished in spite of its many
advantages. FP acquisition time is less than 1 min, while it
provides information on the volume and motion of each
heart chamber and a measurement of its ejection fraction
(EF). In particular, it gives more accurate information on the
right ventricle than available with equilibrium gated angio-
cardiography (MUGA scan) [80]. FP can be repeated
immediately, using tracers that rapidly disappear from the
blood pool or ultra-short-lived radionuclides such as
191mIr
[81], for imaging multiple interventions. FP has been shown
to provide important complementary information to SPECT
MPS [82]. Nevertheless, its usage in the planar mode had
declined for a variety of reasons. In order to reduce the errors
thatresultedfromplanarbackgroundsubtraction,eachcardiac
chamber had its own imaging view and only a few seconds of
optimal time window for acquisition. Therefore the informa-
tion was based on a few cardiac cycles only. A “good bolus”
was required for reliable data and was often non-obtainable in
patients with damaged veins due to chemotherapy, and in
patients with reduced cardiac function. Other serious prob-
lems were caused by the count rate limitations of the Anger
camera. On the one hand, the count rate from a large dose
could exceed the linear range of the counting electronics, yet,
on the other hand, basic gated frames were typically acquired
in approximately 0.1 s and had very few signal counts which
caused errors in the detection of the cardiac wall motion. As
describedearliertheDNMcamerahasthetechnologicalassets
to overcome those technical limitations. In addition, since
DNM is tomographic, background should not be a major
problem and acquisition can be continued for unlimited
cardiac cycles and a “good bolus” may not be essential.
Evolutionary perspective: the potential for increased
resolution
The future of DNM may be the most intriguing question
since the design can be optimized in a variety of directions.
Since nuclear cardiology is concerned today mainly with
imaging of relatively large “cold spots”, of the order of
1 cm or more, the current optimization achieves significant
reduction in acquisition time with conservative improve-
ments in SR (Tables 1 and 3). In addition, currently, any
major improvement of SR would be masked by cardiac
and respiratory motions. However, the imaging entitlement
of the new technology could equally be used to achieve
very high SR if needed and from an evolutionary
perspective, resolution improvement should be given high
priority in the years ahead. In fact, DNM core technology
was developed in the microSPECT environment that has
recently achieved a resolution of 400 μm, while main-
Fig. 11 Upper panel: ROI within the left ventricular cavity. Lower
panel: dynamic time-activity curve of the same ROI, reflecting the
first 90 s of bolus passage
1898 Eur J Nucl Med Mol Imaging (2010) 37:1887–1902taining sufficient sensitivity [36]. Thus, the nuclear
cardiology community may witness in the near future an
evolving line of cameras with continuously improving SR.
The prospect of using gated MPS and/or MDCT data for
improved resolution recovery or for SPECT motion
tracking and de-blurring seems to be a critical next step
[50, 51]. Beyond that obligatory step, an increase in
resolution to allow differentiation between subendocardial—
and subepicardial—myocardium may benefit classic MPS.
An increase in ultimate resolution would also enable a more
accurate CFR measurement by allowing a reduction of
spillover effects from the blood pool into the myocardium
Fig. 12 A 1-day
99mTc-tetrofos-
min study. Upper two rows:
DNM images employing short
acquisition times. Lower two
rows: images of the same patient
acquired by conventional dedi-
cated cardiac SPECT with sig-
nificantly longer acquisition
times. Images are comparable
and both are compatible with
inferoseptal wall ischaemia of
the left ventricular wall extend-
ing to the apical area. Courtesy
of the Department of Nuclear
Medicine, Rambam Hospital,
Israel
Fig. 13 A treadmill stress/rest
201Tl study. a Conventional SPECT
images employing 20 min acquisition for each stress or rest data set. b
DNM image employing only 6 min acquisition for each data set.
Myocardial ischaemia of the inferolateral wall of the left ventricle is
noted on both modalities. VLA vertical long axis, HLA horizontal long
axis. Courtesy of Dr. Iftikhar Ali from Ottawa Heart Institute, Canada
Eur J Nucl Med Mol Imaging (2010) 37:1887–1902 1899andviceversa,asbotheffects are contaminating the respective
time-activity curves.
Wealsoenvisionthatinthenearfutureincreasedresolution
will be a key factor as nuclear cardiology matures within
molecular imaging. While the importance of PET imaging
will continue, unlike PET, SPECT is capable of simultaneous
multiple isotope imaging and additionally, in theory, a better
SRmayultimatelybeachievedwithSPECT.Sinceidentifying
individual patients with vulnerable plaques at high risk for
rupture is a central challenge, various studies including first
clinical trials have been using different tracers for ”hot spot”
plaque imaging studies [83]. Other research targets include
imaging of left ventricular remodelling, angiogenesis,
apoptosis and hypoxia,gene expression, and stem cell therapy,
to delineate a few. Thus we can predict a steady evolution of
nuclear cardiology beyond the assessment of myocardial
perfusion, towards the characterization of molecular events.
Since DNM technology and recent innovative camera designs
[84] have great potential for further improvement, they may
turn out to be the first evolutionary step in linking molecular
biology science and clinical cardiology.
Conclusion
The DNM, an ultra-fast cardiac SPECTcamera, was created to
answer the call of current evolutionary challenges in nuclear
cardiology. It features high sensitivity as well as improved SR,
temporal resolution and ER. It enables reduction of acquisition
time and fast protocols. Importantly, it is inherently tomograph-
ic imaging and features high count rate linearity and therefore is
potentially capable of dynamic 3-D acquisition. The DNM is
designedtooptionallyworkwithMDCT,togethercomprisinga
system of comprehensive, non-invasive, functional and ana-
tomical imaging for the management of CAD.
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